The appaloosa coat spotting pattern in horses is caused by a single incomplete dominant gene (LP). Homozygosity for LP (LP/LP) is directly associated with congenital stationary night blindness (CSNB) in Appaloosa horses. LP maps to a 6cM region on ECA1. We investigated the relative expression of two functional candidate genes located in this LP 
BACKGROUND
Coat color has been a fascinating topic of genetic discussion and discovery for over a century. The pigment genes of mice were one of the first genetic systems to be explored through breeding and transgenic studies. To date at least 127 loci involved in pigmentation have been described (Silver, 1979; Bennett and Lamoreux, 2003) . The genes that affect pigmentation in the skin and hair influence other body systems, and many of these genes have been studied in different mammals. One of the most extensively studied examples is oculocutaneous albinism type 1; a developmental disorder in humans that affects pigmentation in the skin and hair, as well as eye development. This disease is caused by mutations in the tyrosinase gene (TYR), which is involved in the first step of melanin production (Toyofuko et al. 2001; Ray et al. 2007 ).
Horses (Equus caballus) are valued by breeders and enthusiasts for their beauty and variety of coat color and patterns. The genetic mechanisms involved in several different variations of coloration and patterning in horses have been reported including; chestnut, frame overo, cream, black, silver dapple, sabino-1 spotting, tobiano spotting, and dominant white spotting (Marklund et al. 1996; Metallinos et al. 1998; Mariat et al. 2003; Rieder et al. 2003; Brunberg et al. 2006; Brooks and Bailey 2005; Brooks et al. 2007; Haase et al. 2007 ). The mechanism behind appaloosa spotting, a popular coat pattern occurring in several breeds of horses, remains to be elucidated. Likewise, although there are several inherited ocular diseases reported in the horse (cataracts, glaucoma, anterior segment dysgenesis, and congenital stationary night blindness) the modes of inheritance, genetic mutations, and the pathogenesis of these ocular disorders remain unknown.
Appaloosa spotting is characterized by patches of white in the coat which tend to be symmetrical and centered over the hips. In addition to the patterning in the coat, appaloosa horses have three additional pigmentation traits; striped hooves, readily visible non-pigmented sclera around the eye, and mottled pigmentation around the anus, genitalia, and muzzle (Sponenberg and Beaver 1983) . The extent of spotting varies widely among individuals, resulting in a collection of patterns which are termed the leopard complex (Sponenberg et al.1990 ). The spectrum of patterns; with the leopard complex, includes very minimal white patches on the rump (known as a "lace blanket"), a white body with many oval or round pigmented spots dispersed throughout (known as "leopard", from which the genetic locus is named), and nearly complete depigmentation (known as "fewspot") ( Figure 1) . A single autosomal dominant gene, Leopard Complex, (LP) is thought to be responsible for the inheritance of these patterns and associated traits, while modifier genes are thought to play a role in determining the amount of white patterning that is inherited (Miller 1965; Sponenberg et al. 1990; Archer and Bellone unpublished data) . Horses that are homozygous for appaloosa spotting (LP/LP) tend to have fewer spots on the white patterned areas than heterozygotes; these horses are known as fewspots (largely white body with little to no spots) and snowcaps (white over the croup and hips with little to no spots) (Sponenberg et al. 1990; Lapp & Carr 1998 ).
(Figure 1)
We have recently reported an association between homozygosity for LP and congenital stationary night blindness (CSNB) (Sandmeyer et al. 2007) . CSNB is characterized by a congenital and non-progressive scotopic visual deficit (Witzel 1977; Witzel 1977; Witzel 1978; Rebhun 1984) . Affected horses may exhibit apprehension in dimly lit conditions, and may be difficult to train and handle in phototopic (light) and scotopic (dark) conditions (Witzel 1977; Witzel 1977; Witzel 1978; Rebhun 1984) .
Affected animals occasionally manifest a bilateral dorsomedial strabismus (improper eye alignment), and nystagmus (involuntary eye movement) (Rebhun et al. 1984; Sandmeyer et al. 2007) . CSNB is diagnosed by an absent b-wave and a depolarizing a-wave in scotopic (dark-adapted) electroretinography (ERG) (Figure 2 ). This ERG pattern is known as a "negative ERG" (Witzel et al. 1977) . No morphological or ultrastructural abnormalities have been detected in the retinas of horses with CSNB (Witzel et al. 1977; Sandmeyer et al. 2007) . A similar "negative ERG" is seen in the Schubert-Bornshein type of human CSNB (Witzel et al. 1978; Schubert and Bornshein 1952) . This type of CSNB is thought to be caused by a defective neural transmission within the retinal rod pathway (Witzel et al. 1977; Witzel et al. 1978; Sandmeyer et al. 2007 ). Neural transmission is complex and the mechanism of the transmission defect in CSNB is not reported. Rod photoreceptors are most sensitive under scotopic conditions. In the dark these cells exist in a depolarized state. They hyperpolarize in response to light and signaling occurs through reductions in glutamate release (Stryer 1991 ). This hyperpolarization is responsible for the a-wave of the electroretinogram. Normally this results in stimulation of a population of bipolar cells, the ON bipolar cells. The glutamate receptor of the ON bipolar cells is a metabotropic glutamate receptor (MGluR6) and this receptor is expressed only in the retinal bipolar cell layer (Nakanishi 1998; Nomura 1994 ). The MGluR6 receptors sense the reduction in synaptic glutamate and produce a response which depolarizes the ON bipolar cell (Nakanishi 1998). This depolarization is responsible for the b-wave of the electroretinogram. The ERG characteristics of the Schubert-Bornshein type of CSNB are consistent with a failure in depolarization of the ON bipolar cell (Sandmeyer et al. 2007) .
A whole genome scanning panel of microsatellite markers was used to map LP to a 6 cM region on ECA1 (Terry et al. 2004) . Prior to the sequencing of the equine genome, two candidate genes Transient Receptor Potential Cation Channel, Subfamily M, Member 1 (TRPM1) and Oculoctaneous Albinism Type II (OCA2) were suggested based on comparative phenotypes in humans and mice (Terry et al. 2004) . Both TRPM1 and OCA2 were FISH mapped to ECA1, to the same interval as LP (Bellone et al. 2006a) . One SNP in the equine OCA2 gene has been ruled out as the cause for appaloosa spotting (Bellone et al. 2006b ).
TRPM1, also known as Melastatin 1 (MLSN1), is a member of the transient receptor potential (TRP) channel family. Channels in the TRP family may permit Ca 2+ entry into hyperpolarized cells, producing intracellular responses linked to the phosphatidylinositol and protein kinase C signal transduction pathways (Clapham et al. 2001) . TRPs are important in cellular and somatosensory perception (Nilius 2007) .
Defects in a light-gaited TRP channel results in a loss of phototransduction in Drosphila (reviewed in Kim, 2004) . Although the specific function TRPM1 has yet to be described, cellular sensation and intercellular signaling are vital for normal melanocyte migration (reviewed in Steingrímsson et al. 2006) . In mice and humans, the promoter region of this gene contains four consensus binding sites for a melanocyte transcription factor, MITF Zhigi et al. 2004) . One of these sites, termed an M-box, is unique to melanocytic expression . TRPM1 is downregulated in highly metastatic melanoma cells, suggesting that this protein plays an important role in normal melanogenesis (Duncan et al.1998) .
Mutations in the OCA2 gene (also P, or pink-eyed dilution) cause hypopigmentation phenotypes in mice (Gardner et al. 1992) . Similarly, in humans mutations in OCA2 cause the most common form of albinism (Lee et al. 1994) .
Additionally, other mutations in this gene are thought to be responsible for the variation in human eye color (Duffy et al. 2007; Eiberg et al. 2008) . It is believed that during melanogenesis this protein functions to control intramelanasomal pH and aids in tryosinase processing (Sturm et al. 2001; Ni-Komatsu and Orlow 2006) . 
MATERIALS AND METHODS

Horses and genotype categories:
Horses were categorized according to genotype and phenotype for LP which was diagnosed by coat color assessment, breeding records, and for those horses used in the retinal study also by ocular examination including scotopic electroretinography (ERG). Horses were included in the LP/LP group if they had a few spot leopard or snow cap blanket pattern and a scotopic ERG consistent with CSNB ( Figure 1a ). Horses in the LP/lp group all displayed white patterning with dark spots and/or had breeding records consistent with heterozygosity ("leopard", "spotted blanket", or "lace blanket" patterns) and a normal scotopic ERG. Horses were included in the nonappaloosa (lp/lp) group if they were solid-colored and showed no other traits associated with the presence of LP (striped hooves, white sclera, and mottled skin) and a normal scotopic ERG. The non-appaloosa horses were from the Thoroughbred and American Quarter Horse breeds; two breeds that are not known to possess any appaloosa spotted individuals. Due to the invasive nature of some of the experiments performed it was impossible to obtain a significant number of samples from age, sex, and base coat color matched horses. Both male and female horses were used in this study, horses ranged in age from less than a year to 23 years old and the base coat colors black, bay, and chestnut were all represented (Table 5) Auriculopalpebral nerve blocks were performed using 2 mL of a 2% lidocaine hydrochloride injectable solution (Bimeda-MTC Animal Health Inc. Cambridge, ON, Canada). Scotopic ERGs were completed bilaterally to indentify nyctalopia and CSNB. A corneal DTL™ microfiber electrode (DTL Plus Electrode, Diagnosys LLC, Littleton, MA) was placed on the cornea, and platinum subdermal needle electrodes (Cadwell Low Profile Needle electrodes, Cadwell Laboratories, Kenewick, WA) were used as reference and ground. The reference electrode was placed subdermally 3 cm from the lateral canthus and the ground electrode was placed subdermally over the occipital bone. The ERGs were elicited with a white xenon strobe light and recorded with a Cadwell Sierra II (Cadwell Laboratories) with the bandwidth set at 0.3-500 Hz. eyelids were held open manually for each test and a pseudo Ganzfeld was used to attempt even stimulation of the entire retina (Komaromy et al. 2003) . Horses were dark adapted for 25 minutes and darkadapted ERG responses were stimulated using maximum light intensity with each recording represented the average of 20 responses. An a-wave dominated ERG or "negative ERG" was considered diagnostic of CSNB (Witzel et al. 1977; Sandmeyer et al. 2007) . Horses included in the LP/LP (n=4) group had a "negative ERG", those in the LP/lp group (n=4) and lp/lp group (n=6) had normal scotopic and phototopic electroretinograms ( Figure 2 , Table 1 ). 2-mercaptoethanol, followed by differential alcohol and salt precipitations (Chomczynski and Sacch 1987; MacLeod et al. 1996) . All samples were stored at -80°C.
Retina and collection and RNA isolation:
Quantitative real-time RT-PCR: RNA was quantified using a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE) and sample concentrations were adjusted to 50ng/ul with RNAse free water (Ambion, Austin, TX).
RNA integrity and purity was verified using a Bioanalyzer (Agilent Technologies, Santa Clara, CA). All skin and retinal samples isolated where of high purity and integrity, all samples used had RNA integrity numbers greater than eight.
Equine homologs for TRPM1, OCA2, TJP1, MTMR10, and OTUD7A were identified from the Entrez Trace Archive using a Discontiguous Megablast (http://www.ncbi.nih.gov/BLAST) or by a BLAT search against the horse January 2007 (equCab1) assembly (http://www.genome.ucsc.edu/). Taqman primers and probes were designed as previously described (Murphy et al. 2006) . Preliminary experiments revealed that β-Actin was the most stable reference gene among those tested in our samples. The PCR efficiency of primer/probe combinations were calculated using serial dilutions of RNA spanning a magnitude of 8 fold (or greater) by the REST analysis program (Pfaffl et al. 2002) . R 2 values for standard curves were ≥ 0.98 for all products tested ( Table 2) . All primer pairs were tested to ensure that genomic DNA was not being amplified by using a minus reverse transcription control in each assay. Table 4 ). However, gene expression values for heterozygotes were not half the difference between appaloosa homozygotes and nonappaloosa horses indicating that the difference is not a simple dosage effect. Relative expression differences at or near this magnitude were not detected for any of the other genes tested from this chromosome region ( Figure 4B ). When compared to mRNA from non-appaloosa skin samples, small changes with less stringent p-values were detected for OCA2 and MTMR10 in LP/lp and LP/LP unpigmented skin samples respectively (Table   4 ). These small changes are likely due to the generalized difference between pigmented and unpigmented skin rather than a direct effect of LP.
In humans TRPM1 is expressed in several isoforms (Xu et al. 2001; Fang and Setaluri 2000) . The long isoform, termed MLSN-L, is thought to be responsible for Ca 2+ influx (Xu et al. 2001) . Primers and probes were designed to specifically detect this long isoform. It is possible the large relative expression difference that we detected for the long isoform of TRPM1 may interfere with Ca 2+ signaling in the melanocytes and thus participate in the biological mechanisms of appaloosa spotting.
The specific function of TRPM1 in melanocytes remains unknown. It has been described as a tumor suppressor that may regulate the metastatic potential of melanomas, as its expression declines with increased metastatic potential (Duncan et al 1998; Deeds et al. 2000; Duncan et al. 2001) . Treatment of pigmented melanoma cells with a differentiation inducing agent up-regulated the long isoform of this gene (Fang and Setaluri 2000) . TRPM1 therefore has potential roles in Ca 2+ dependent signaling related to melanocyte proliferation, differentiation, and/or survival.
One potential role of TRPM1 in melanocyte survival is in interaction with the signaling pathway of the cell surface tyrosine kinase receptor, KIT, and its ligand KITLG. Signaling through the KIT receptor is critical for the growth, survival and migration of melanocyte precursors (reviewed by Erikson, 1993) . It has been shown that both Phospholipase C activation and Ca 2+ influx are important in supporting KIT positive cells (Berger 2006) . Stimulation with KIT ligand while blocking Ca 2+ influx led to a novel form of cell death that is termed activation enhanced cell death (AECD) (Gommerman and Berger 1998) . It is possible that during melanocyte proliferation and differentiation, when KIT positive cells are stimulated by the ligand in vivo, the absence of TRPM1 expression may result in decreased Ca 2+ influx and ultimately result in AECD. Early melanocyte death could therefore explain LP hypopigmentation patterns.
Notably, TRPM1 expression in pigmented skin from heterozygous (LP/lp) horses did not differ significantly from that of non-appaloosa horses. TRPM1 expression is likely tissue specific as we found 4000-times greater expression in retina than skin (p=0.001). Similarly, temporal regulatory elements may direct relatively higher expression in migrating melanocyte precursors than in mature melanocytes, thus in the skin we may not be measuring expression at the biological relevant time point. Our findings suggest that downregulation of TRPM1 in the retina of homozygous (LP/LP) horses is responsible for CSNB. We have also shown an association between decreased TRPM1 expression and unpigmented LP/lp skin. However, further work is required to rule out the possibility that decreased expression of TRPM1 in unpigmented LP/lp skin when compared to non-appaloosa skin may simply reflect an absence of TRPM1 expressing melanocytes.
Summary and prospects:
LP has been mapped to a 6 cM region on ECA1
containing the candidate genes TRPM1 and OCA2 (Terry et al., 2004; Bellone et al. 2006a ). In addition, CSNB has been associated with homozygosity for LP (Sandmeyer et al., 2007) . Here we report that TRPM1 is the only gene from this candidate region that is significantly downregulated in the retina and skin of LP/LP horses. The previously published mapping data, in connection with this reported gene expression data, support the hypothesis that TRPM1 is the molecular mechanism for both LP and CSNB.
This report is the first describing a gene expressional mechanism associated with an eye disease and coat color phenotype in the horse. Future work will include investigation of coding and regulatory regions by sequence analysis to identify the basis of the observed TRPM1 differential expression. As previously mentioned, three E-boxes and one M-box have been identified in the proximal promoter of this gene in humans and mouse. The newly available assembled equine genome will be used to identify and investigate regions of interest for evidence of mutations in these regulatory elements.
Many of the genes involved in melanogenesis have distinct distal regulatory elements that control their expression. For example, TYR has a distal regulatory element specific to melanocytes 15 kB away from the start of transcription (Porter et al. 1991; Ganss et al.1994; Porter and Meyer 1994) . Novel distal regulatory elements of TRPM1 are likely to be identified. Appaloosa spotted horses may serve as an important research tool illustrating the role of TRPM1 in normal night vision and melanogenesis. Although several mutations have been identified as the cause of CSNB in humans (Dryja et al. 2005; Zeitz et al. 2006; Xiao et al. 2006; Szabo et al. 2007) none to date involve TRPM1.
Thus, the horse could serve as a model for
T as yet unsolved forms of heritable human CSNB. In addition, mutations in CABP4, a member of the calcium binding protein family, were recently shown to cause a 30-40% reduction in transcript levels and result in an autosomal recessive form of CSNB in humans (Zeitz et al. 2006) .Therefore, studying the molecular interaction of TRPM1 and other genes causing CSNB involved in calcium signaling could lead to a better understanding of signal transduction during night vision. 
